Cancer Family
Adnexal Neoplasm
CI-CAN-00000005Explore in graph →
Non-malignant776 active trials5 approved drugs94 evidence items
- NCIt
- C212119
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000005Explore in graph →
Clinical trials
3,521 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00003644 | Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer | completed | Phase 3 | 571 | Gynecologic Oncology GroupNETWORK | 2 | Jun 4, 2019 | clinicaltrials |
| NCT00003214 | Chemosensitivity Testing to Assign Treatment for Patients With Stage III or Stage IV Ovarian Cancer | completed | Phase 3 | 300 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT00011986 | Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer | completed | Phase 3 | 4,312 | Gynecologic Oncology GroupNETWORK | 1 | Apr 16, 2019 | clinicaltrials |
| NCT01846611 | A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 581 | Janssen Research & Development, LLCINDUSTRY | 10 | Apr 1, 2019 | clinicaltrials |
| NCT00426257 | Secondary Debulking Surgery +/- Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer | completed | Phase 3 | 242 | The Netherlands Cancer InstituteOTHER | 1 | Aug 24, 2018 | clinicaltrials |
| NCT02107066 | Women's Activity and Lifestyle Study in Connecticut(WALC) | completed | Phase 3 | 144 | Yale UniversityOTHER | 1 | Apr 20, 2018 | clinicaltrials |
| NCT00443196 | Testing Drug Sensitivity of Ovarian, Fallopian and Primary Peritoneal Adenocarcinomas | completed | Phase 2 / Phase 3 | 150 | Pierian BiosciencesINDUSTRY | 1 | Mar 12, 2018 | clinicaltrials |
| NCT01015118 | LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian Cancer | completed | Phase 3 | 1,366 | Boehringer IngelheimINDUSTRY | 22 | Dec 7, 2017 | clinicaltrials |
| NCT00434642 | A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma(OCEANS) | completed | Phase 3 | 484 | Genentech, Inc.INDUSTRY | 0 | Aug 9, 2017 | clinicaltrials |
| NCT01684878 | Pertuzumab in Platinum-Resistant Low Human Epidermal Growth Factor Receptor 3 (HER3) Messenger Ribonucleic Acid (mRNA) Epithelial Ovarian Cancer (PENELOPE) | completed | Phase 3 | 208 | Hoffmann-La RocheINDUSTRY | 10 | May 23, 2017 | clinicaltrials |
| NCT02311907 | Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer | completed | Phase 3 | 195 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01704651 | Accelerating Gastrointestinal Recovery | completed | Phase 3 | 146 | Jamie N. Bakkum-GamezOTHER | 1 | Oct 24, 2016 | clinicaltrials |
| NCT00437307 | Hycamtin Plus Carboplatin Versus Established Regimens for the Treatment of Ovarian Cancer Relapse(HECTOR) | completed | Phase 3 | 550 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Sep 22, 2016 | clinicaltrials |
| NCT00382811 | OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer(OVATURE) | completed | Phase 3 | 142 | MEI Pharma, Inc.INDUSTRY | 7 | Jul 18, 2016 | clinicaltrials |
| NCT00033605 | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis | completed | Phase 3 | 130 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 13, 2016 | clinicaltrials |
| NCT01239732 | A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer | completed | Phase 3 | 1,021 | Hoffmann-La RocheINDUSTRY | 37 | Jun 10, 2016 | clinicaltrials |
| NCT02728622 | Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane | completed | Phase 3 | 241 | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 0 | Apr 5, 2016 | clinicaltrials |
| NCT00006453 | Carboplatin With or Without Gemcitabine in Treating Patients With Advanced Ovarian Epithelial Cancer That Has Not Responded to Previous Chemotherapy | completed | Phase 3 | — | AGO Study GroupOTHER | 2 | Dec 23, 2015 | clinicaltrials |
| NCT00006454 | Paclitaxel Plus Carboplatin With or Without Topotecan in Treating Patients With Stage IIB, Stage III, or Stage IV Ovarian Epithelial Cancer | completed | Phase 3 | — | AGO Study GroupOTHER | 1 | Dec 23, 2015 | clinicaltrials |
| NCT00043082 | S0200 Carboplatin With or Without Doxil in Patients With Recurrent Ovarian Cancer | completed | Phase 3 | 61 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 26, 2015 | clinicaltrials |
| NCT00003636 | Chemotherapy Plus Surgery in Treating Patients With Stage III or Stage IV Ovarian, Peritoneal, or Fallopian Tube Cancer | completed | Phase 3 | 704 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 15 | Aug 5, 2015 | clinicaltrials |
| NCT01196741 | Saracatinib and Paclitaxel in Platinum-resistant Ovarian Cancer(SaPPrOC) | completed | Phase 2 / Phase 3 | 107 | University College, LondonOTHER | 1 | May 5, 2015 | clinicaltrials |
| NCT00003120 | S9701 Paclitaxel in Treating Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Remission | completed | Phase 3 | 308 | SWOG Cancer Research NetworkNETWORK | 1 | Oct 9, 2014 | clinicaltrials |
| NCT00002641 | Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma | completed | Phase 3 | 350 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 13 | Aug 8, 2014 | clinicaltrials |
| NCT00113607 | An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer | completed | Phase 3 | 672 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 20 | Jun 27, 2014 | clinicaltrials |
| NCT00052468 | Carboplatin/Paclitaxel +/-Gemcitabine in Treating Patients With Ovarian Epithelial or Fallopian Tube Cancer(AGO-OVAR9) | completed | Phase 3 | 1,742 | AGO Study GroupOTHER | 4 | Jun 25, 2014 | clinicaltrials |
| NCT00850772 | Early Post-Operative Enteral Feeding in Patients With Advanced Epithelial Ovarian Cancer(OPEN) | completed | Phase 3 | 109 | Queensland Centre for Gynaecological CancerOTHER_GOV | 1 | Jun 12, 2014 | clinicaltrials |
| NCT00989131 | Study of Paclitaxel in Patients With Ovarian Cancer | completed | Phase 3 | 789 | Oasmia Pharmaceutical ABINDUSTRY | 16 | Feb 4, 2014 | clinicaltrials |
| NCT00189553 | Caelyx Plus Carboplatin Versus Paclitaxel Plus Carboplatin in Patients With Epithelial Ovarian Cancer in Late Relapse(CALYPSO) | completed | Phase 3 | 976 | ARCAGY/ GINECO GROUPOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00002894 | Platinum-based Chemotherapy With or Without Paclitaxel in Treating Patients With Relapsed Ovarian Cancer | completed | Phase 3 | 800 | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003998 | Carboplatin Plus Paclitaxel or Docetaxel in Treating Patients With Ovarian Epithelial Cancer | completed | Phase 3 | 1,050 | University of GlasgowOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002895 | Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 3 | 1,400 | Medical Research CouncilOTHER_GOV | 10 | Dec 4, 2013 | clinicaltrials |
| NCT00003695 | Chemotherapy With or Without Surgery in Treating Patients With Stage II or Stage III Ovarian Cancer | completed | Phase 3 | 1,000 | Medical Research CouncilOTHER_GOV | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00004921 | High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | completed | Phase 3 | — | EBMT Solid Tumors Working PartyOTHER | 9 | Sep 17, 2013 | clinicaltrials |
| NCT00263822 | Erlotinib or Observation in Treating Patients Who Have Undergone First-Line Chemotherapy for Ovarian Cancer, Peritoneal Cancer, or Fallopian Tube Cancer | completed | Phase 3 | 835 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Aug 27, 2013 | clinicaltrials |
| NCT00075712 | Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer | completed | Phase 2 / Phase 3 | 150 | Royal College of Obstetricians and GynecologistsOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00483782 | Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer | completed | Phase 3 | 1,520 | Medical Research CouncilOTHER_GOV | 5 | Aug 12, 2013 | clinicaltrials |
| NCT00098878 | Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | completed | Phase 3 | 1,300 | NHS Greater Glasgow and ClydeOTHER | 3 | Aug 7, 2013 | clinicaltrials |
| NCT00005590 | Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma | completed | Phase 3 | — | Cancer Research Campaign Clinical Trials CentreOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00002568 | Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial Cancer | completed | Phase 3 | 470 | Gynecologic Oncology GroupNETWORK | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00170690 | Preference Study With Elderly Patients Recurrent Ovarian Cancer | completed | Phase 3 | 123 | North Eastern German Society of Gynaecological OncologyOTHER | 1 | Jun 3, 2013 | clinicaltrials |
| NCT00002717 | Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal Cancer | completed | Phase 3 | 324 | Gynecologic Oncology GroupNETWORK | 1 | May 27, 2013 | clinicaltrials |
| NCT00003322 | Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer | completed | Phase 3 | 384 | Gynecologic Oncology GroupNETWORK | 2 | May 27, 2013 | clinicaltrials |
| NCT00004934 | Paclitaxel and Carboplatin With or Without Epirubicin in Treating Patients With Stage IIB, Stage III, or Stage IV Invasive Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | completed | Phase 3 | — | Nordic Society of Gynaecological Oncology - Clinical Trials UnitOTHER | 10 | Feb 4, 2013 | clinicaltrials |
| NCT00327444 | Study of the Effect of Intravenous AVE0005 (VEGF Trap) in Advanced Ovarian Cancer Patients With Recurrent Symptomatic Malignant Ascites | completed | Phase 2 / Phase 3 | 58 | SanofiINDUSTRY | 9 | Jan 1, 2013 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00004166 | Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy | completed | Phase 3 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00102973 | TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 244 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00243685 | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis | completed | Phase 2 / Phase 3 | 150 | Pierian BiosciencesINDUSTRY | 1 | Jan 26, 2012 | clinicaltrials |
Data updated 22 days agoSource updated Jun 4, 2019source: clinicaltrials